1-(1-Methyl-1H-indol-3-yl)-3-phenyl-propenone

ID: ALA1834559

PubChem CID: 11448376

Max Phase: Preclinical

Molecular Formula: C18H15NO

Molecular Weight: 261.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(C(=O)/C=C/c2ccccc2)c2ccccc21

Standard InChI:  InChI=1S/C18H15NO/c1-19-13-16(15-9-5-6-10-17(15)19)18(20)12-11-14-7-3-2-4-8-14/h2-13H,1H3/b12-11+

Standard InChI Key:  VOOOMMHNKOQVAH-VAWYXSNFSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -1.9722   -9.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9733  -10.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2585  -10.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2603   -9.0283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5450   -9.4374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5401  -10.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2517  -10.5205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7362   -9.8453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2438   -9.1760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5112  -11.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4942   -8.3899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3000   -8.2136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0615   -7.7802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8556   -8.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6615   -8.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2151   -9.2577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0202   -9.0819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2712   -8.2951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7108   -7.6840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9077   -7.8629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  7 10  1  0
  5  6  1  0
  9 11  1  0
 11 12  1  0
  2  3  1  0
 11 13  2  0
  3  6  2  0
 12 14  2  0
  1  2  2  0
 14 15  1  0
  5  4  2  0
 15 16  2  0
  6  7  1  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
  8  9  2  0
 18 19  1  0
  9  5  1  0
 19 20  2  0
 20 15  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

RT-112 (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 261.32Molecular Weight (Monoisotopic): 261.1154AlogP: 4.07#Rotatable Bonds: 3
Polar Surface Area: 22.00Molecular Species: HBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.21CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.51Np Likeness Score: -0.35

References

1. Martel-Frachet V, Kadri M, Boumendjel A, Ronot X..  (2011)  Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents.,  19  (20): [PMID:21908193] [10.1016/j.bmc.2011.08.015]

Source